Farallon Capital Management’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-500,000
Closed -$3.65M 106
2019
Q1
$3.65M Sell
500,000
-1,500,000
-75% -$14.7M 0.03% 89
2018
Q4
$18.3M Buy
2,000,000
+930,000
+87% +$10.3M 0.13% 68
2018
Q3
$13.3M Sell
1,070,000
-370,000
-26% -$5.01M 0.08% 80
2018
Q2
$22M Buy
+1,440,000
New +$24.9M 0.14% 62
2014
Q1
Sell
-100,000
Closed -$1.96M 94
2013
Q4
$1.96M Buy
+100,000
New +$1.46M 0.04% 72

Other funds holding DVAX

Farallon Capital Management's DVAX Position: Q2 2019 in Review

Farallon Capital Management sold out of Dynavax Technologies (DVAX) in Q2 2019, closing a stake of 500,000 shares — an estimated $3.65M sold.

Farallon Capital Management first reported a position in DVAX in Q4 2013 and held it in 5 quarters. The position peaked at $22M in Q2 2018. 127 funds tracked by Wall St. Rank hold DVAX as of Q2 2019.

  • Farallon Capital Management reported no remaining Dynavax Technologies position as of Q2 2019 after selling out during the quarter.
  • Farallon Capital Management sold 500,000 Dynavax Technologies shares in Q2 2019, an estimated $3.65M.
  • Farallon Capital Management first reported a position in Dynavax Technologies in Q4 2013 and held it in 5 quarters.
  • Farallon Capital Management's Dynavax Technologies position peaked at $22M in Q2 2018.
  • 127 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2019.

Based on Farallon Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.